SCHEMBL27725302

SCHEMBL27725302

COC(=O)CC[C@H](NC(=O)c1ccc(CCCC=O)cc1)C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 8/20 0.50
▸ TAS1R1 Q7RTX1 8/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ LNPEP Q9UIQ6 3/20 0.42
▸ ERAP1 Q9NZ08 1/20 0.42
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ MAPK14 Q16539 2/20 0.41
▸ GAA P10253 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ERAP2 Q6P179 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27905011 1.00 TAS1R3 (0.50) TAS1R3TAS1R1L3MBTL1LNPEPERAP1
SCHEMBL28757793 0.87 L3MBTL1 (0.51) TAS1R3TAS1R1L3MBTL1GAAKMT2A
SCHEMBL27905010 0.83 TAS1R3 (0.43) TAS1R3TAS1R1L3MBTL1LNPEPERAP1
SCHEMBL27639464 0.80 TAS1R3 (0.46) TAS1R3TAS1R1L3MBTL1LNPEPCA12
SCHEMBL27639462 0.80 TAS1R3 (0.46) TAS1R3TAS1R1L3MBTL1LNPEPCA12
SCHEMBL7571102 0.80 L3MBTL1 (0.53) TAS1R3TAS1R1L3MBTL1KMT2A
SCHEMBL8972761 0.79 L3MBTL1 (0.52) TAS1R3TAS1R1L3MBTL1LNPEPCA12
SCHEMBL28774100 0.79 DHFR (0.58) CA1CA2
SCHEMBL27546846 0.79 DHFR (0.58) CA1CA2
SCHEMBL24142085 0.78 L3MBTL1 (0.51) TAS1R3TAS1R1L3MBTL1LNPEPERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111087321-A Purification method of pemetrexed disodium intermediate 山东安弘制药有限公司 2020-05-01 — — CN disclosed
CN-103086912-A Method for preparing pemetrexed and pemetrexed intermediate HUBEI HALFSKY PHARMACY CO LTD 2013-05-08 — — CN disclosed
CN-101333173-B N-[4-(butanal-4-group)-benzoyl]-L-glutamic acid dimethyl ester compound and method for preparing pemetrexed by using the compounds QILU PHARMACEUTICAL CO LTD 2011-08-10 — — CN disclosed
CN-101333173-A N-[4-(butanal-4-group)-benzoyl]-L-glutamic acid dimethyl ester compound and method for preparing pemetrexed by using the compounds QILU PHARMACEUTICAL CO LTD (CN) 2008-12-31 — — CN disclosed
Send feedback